Mucker, E.M.; Brocato, R.L.; Principe, L.M.; Kim, R.K.; Zeng, X.; Smith, J.M.; Kwilas, S.A.; Kim, S.; Horton, H.; Caproni, L.;
et al. SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model. Vaccines 2022, 10, 1104.
https://doi.org/10.3390/vaccines10071104
AMA Style
Mucker EM, Brocato RL, Principe LM, Kim RK, Zeng X, Smith JM, Kwilas SA, Kim S, Horton H, Caproni L,
et al. SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model. Vaccines. 2022; 10(7):1104.
https://doi.org/10.3390/vaccines10071104
Chicago/Turabian Style
Mucker, Eric M., Rebecca L. Brocato, Lucia M. Principe, Robert K. Kim, Xiankun Zeng, Jeffrey M. Smith, Steven A. Kwilas, Sungwon Kim, Helen Horton, Lisa Caproni,
and et al. 2022. "SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model" Vaccines 10, no. 7: 1104.
https://doi.org/10.3390/vaccines10071104
APA Style
Mucker, E. M., Brocato, R. L., Principe, L. M., Kim, R. K., Zeng, X., Smith, J. M., Kwilas, S. A., Kim, S., Horton, H., Caproni, L., & Hooper, J. W.
(2022). SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model. Vaccines, 10(7), 1104.
https://doi.org/10.3390/vaccines10071104